Post-translational modifications in tumor-associated carbonic anhydrases

被引:0
作者
Anna Di Fiore
Claudiu T. Supuran
Andrea Scaloni
Giuseppina De Simone
机构
[1] Istituto di Biostrutture e Bioimmagini-CNR,NEUROFARBA Department, Pharmaceutical and Nutraceutical Section
[2] University of Firenze,Proteomics and Mass Spectrometry Laboratory, ISPAAM
[3] National Research Council,undefined
来源
Amino Acids | 2022年 / 54卷
关键词
Carbonic anhydrase IX; Carbonic anhydrase XII; Post-translational modifications ; Drug design;
D O I
暂无
中图分类号
学科分类号
摘要
Human carbonic anhydrases IX (hCA IX) and XII (hCA XII) are two proteins associated with tumor formation and development. These enzymes have been largely investigated both from a biochemical and a functional point of view. However, limited data are currently available on the characterization of their post-translational modifications (PTMs) and the functional implication of these structural changes in the tumor environment. In this review, we summarize existing literature data on PTMs of hCA IX and hCA XII, such as disulphide bond formation, phosphorylation, O-/N-linked glycosylation, acetylation and ubiquitination, highlighting, when possible, their specific role in cancer pathological processes.
引用
收藏
页码:543 / 558
页数:15
相关论文
共 993 条
[1]  
Aggarwal M(2013)Structural annotation of human carbonic anhydrases J Enzyme Inhib Med Chem 28 267-277
[2]  
Boone CD(2014)Structural insight into activity enhancement and inhibition of H64A carbonic anhydrase II by imidazoles IUCrJ 1 129-135
[3]  
Kondeti B(2019)Dynamic allostery-based molecular workings of kinase: peptide complexes Proc Natl Acad Sci USA 116 15052-15061
[4]  
McKenna R(2009)Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX Proc Natl Acad Sci USA 106 16233-16238
[5]  
Aggarwal M(2012)Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms? Chem Rev 112 4421-4468
[6]  
Kondeti B(2014)The structural comparison between membrane-associated human carbonic anhydrases provides insights into drug design of selective inhibitors Biopolymers 101 769-778
[7]  
Tu C(2019)Biochemical and structural insights into carbonic anhydrase XII/Fab6A10 complex J Mol Biol 431 4910-4921
[8]  
Maupin CM(2018)The proteoglycan-like domain of carbonic anhydrase IX mediates non-catalytic facilitation of lactate transport in cancer cells Oncotarget 9 27940-27957
[9]  
Silverman DN(2019)Molecular insights into cancer drug resistance from a proteomics perspective Expert Rev Proteomics 16 413-429
[10]  
McKenna R(2020)Carbonic anhydrase inhibitors targeting metabolism and tumor microenvironment Metabolites 68 3505-3515